GLORIA LOPEZ: Open Payments
NPI 1427451566 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 35 payments from 12 companies in 2025. Trend: 2023 $761 · 2024 $625 · 2025 $1,003
Food & beverage: $928Education: $75
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $195 |
| Janssen Biotech, Inc. | 7 | $185 |
| ABBVIE INC. | 6 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $115 |
| GENZYME CORPORATION | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Amgen Inc. | 4 | $74 |
| LEO Pharma Inc. | 1 | $29 |
| Cipher Pharmaceuticals US LLC | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, SKYRIZI, OTEZLA, COSENTYX, LIBTAYO, SPEVIGO.
Industry payments across FL — which companies pay providers there.
